$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive Has More To Offer Than The Street Thinks
04:52pm, Thursday, 11'th Mar 2021
NuVasive didn't have a particularly good fourth quarter; COVID-19 was a definite challenge, but the company underperformed its peers/rivals.
NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout
08:21am, Monday, 01'st Mar 2021
NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.
NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines
09:51am, Friday, 26'th Feb 2021
NuVasive (NUVA) registers strong international performance in Q4 along with continued adoption of advanced material science implants in the U.S. Spinal Hardware business.
NuVasive's (NUVA) CEO Chris Barry on Q4 2020 Results - Earnings Call Transcript
12:45am, Friday, 26'th Feb 2021
NuVasive's (NUVA) CEO Chris Barry on Q4 2020 Results - Earnings Call Transcript
NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area
08:33am, Monday, 08'th Feb 2021
SAN DIEGO, Feb. 8, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat
SAN DIEGO, Jan. 5, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat
NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference
04:07pm, Monday, 04'th Jan 2021
SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat
Here's Why You Should Hold on to NuVasive (NUVA) Stock for Now
10:41am, Monday, 04'th Jan 2021
Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently launched products as well as potential in its U.S. Surgical Support business.
NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
04:03pm, Monday, 23'rd Nov 2020
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integra
Were These Hedge Funds Wrong About Betting On NuVasive, Inc. (NUVA)?
03:04pm, Monday, 09'th Nov 2020
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions
NuVasive, Inc. (NUVA) CEO Chris Barry on Q3 2020 Results - Earnings Call Transcript
11:12pm, Thursday, 29'th Oct 2020
NuVasive, Inc. (NUVA) CEO Chris Barry on Q3 2020 Results - Earnings Call Transcript
DiFusion’s New ZFUZE Biomaterial Data Beats Titanium in Multiple Studies
12:00am, Tuesday, 20'th Oct 2020
DiFusion unveiled osteoimmunology data at NASS 2020 demonstrating superiority of ZFUZE biomaterial over Nano-Surfaced Titanium and conventional PEEK
Implanet and SeaSpine Announce FDA Clearance of the Mariner Cap System
12:00am, Monday, 19'th Oct 2020
Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology compan
NuVasive, Inc. (NASDAQ:NUVA) Shares Sold by State of Alaska Department of Revenue
04:24am, Sunday, 18'th Oct 2020
State of Alaska Department of Revenue lessened its stake in shares of NuVasive, Inc. (NASDAQ:NUVA) by 4.1% during the third quarter, according to the company in its most recent disclosure with the Sec
Honeywell: Detecting And Cleansing The Air Of COVID-19 (NYSE:HON)
12:29pm, Friday, 16'th Oct 2020
There is growing evidence that COVID-19 can spread through the air. This is concerning as society tries to get back to normal and open schools, stores and restaurants.
Sign In
Buy NUVA